ANDREW MASTRO: Open Payments
NPI 1427585132 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198,704 in 556 payments from 24 companies in 2025. Trend: 2023 $50,490 · 2024 $162,661 · 2025 $198,704
Consulting: $78,655Speaker / faculty: $75,969Travel & lodging: $31,540Food & beverage: $9,514Honoraria: $3,025
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 67 | $39,453 |
| ABBVIE INC. | 45 | $26,772 |
| Janssen Biotech, Inc. | 64 | $21,050 |
| Regeneron Healthcare Solutions, Inc. | 59 | $18,897 |
| Lilly USA, LLC | 50 | $17,234 |
| Incyte Corporation | 40 | $13,733 |
| LEO Pharma Inc. | 46 | $13,266 |
| PFIZER INC. | 29 | $11,282 |
| GENZYME CORPORATION | 21 | $11,075 |
| UCB, Inc. | 19 | $5,791 |
Products named: Zoryve, DUPIXENT, TREMFYA, EBGLYSS, LITFULO, ANZUPGO, OPZELURA, ADBRY.
Industry payments across IL — which companies pay providers there.
